PROCHLORPERAZINE MALEATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for prochlorperazine maleate and what is the scope of patent protection?

Prochlorperazine maleate is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Watson Labs, Ajanta Pharma Ltd, Amneal, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Leading, Norvium Bioscience, Novitium Pharma, Teva Pharms, Zydus Lifesciences, and Jubilant Cadista, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for prochlorperazine maleate. Twenty-eight suppliers are listed for this compound.

Summary for PROCHLORPERAZINE MALEATE

US Patents:	0
Tradenames:	4
Applicants:	15
NDAs:	22
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	28
Raw Ingredient (Bulk) Api Vendors:	125
Patent Applications:	7,335
Drug Prices:	Drug price trends for PROCHLORPERAZINE MALEATE
Drug Sales Revenues:	Drug sales revenues for PROCHLORPERAZINE MALEATE
What excipients (inactive ingredients) are in PROCHLORPERAZINE MALEATE?	PROCHLORPERAZINE MALEATE excipients list
DailyMed Link:	PROCHLORPERAZINE MALEATE at DailyMed

See drug prices for PROCHLORPERAZINE MALEATE

Drug Sales Revenue Trends for PROCHLORPERAZINE MALEATE

See drug sales revenues for PROCHLORPERAZINE MALEATE

Pharmacology for PROCHLORPERAZINE MALEATE

Drug Class	Phenothiazine

Anatomical Therapeutic Chemical (ATC) Classes for PROCHLORPERAZINE MALEATE

N05AB	Phenothiazines with piperazine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

N05AB	Phenothiazines with piperazine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for PROCHLORPERAZINE MALEATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	PROCHLORPERAZINE	prochlorperazine maleate	TABLET;ORAL	085178-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	040120-002	Jul 11, 1996		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Sub Teva Pharms	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	040162-001	Jan 20, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	216595-002	Mar 17, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glenmark Pharms Ltd	PROCHLORPERAZINE MALEATE	prochlorperazine maleate	TABLET;ORAL	216595-001	Mar 17, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.